31Indexed trials
mesh condition
Neurodevelopmental Disorders
Intelligence
Neurodevelopmental Disorders intelligence: 31 indexed trials, 12 recruiting studies, 27 sponsors across 26 countries.
12Recruiting
27Sponsors
26Countries
Leading sponsors
Hospices Civils de Lyon33 recruiting
The University of Queensland20 recruiting
Neurolab Plus20 recruiting
Centre Hospitalier Intercommunal Creteil11 recruiting
Connecta Therapeutics, S.L.11 recruiting
Douglas Sears10 recruiting
Chinese University of Hong Kong11 recruiting
Hoffmann-La Roche10 recruiting
Göteborg University10 recruiting
IWK Health Centre10 recruiting
Kuwait University11 recruiting
Centre for Chronic Disease Control, India11 recruiting
Geographic activity
United States8trials
France7trials
Australia3trials
Canada2trials
United Kingdom2trials
Kazakhstan2trials
Italy2trials
Spain2trials
Germany1trials
Kuwait1trials
Brazil1trials
Japan1trials
Leading interventions
Assisted Telemedicine1trials
BNBD-NDD Intervention1trials
Brain MRI (structural and functional)1trials
CTH1201trials
CTH120 placebo hard capsules1trials
Cognitive assessment1trials
Continuous Theta Burst Stimulation to Bilateral DLPFC1trials
Controllo1trials
Cyproheptadine1trials
Description of an adult population diagnosed late with a neurodevelopmental disorder1trials
ENGAGE approach (child-oriented goal-setting)1trials
Adult Registered Speech1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.